Here's Why You Should Retain Ventas Stock in Your Portfolio Now
Rising healthcare spending and aging population aid Ventas' senior housing operating portfolio. However, tenant concentration and high interest rates are risks.
Ventas: Net Operating Income Growth Concentrated In Senior Housing
Ventas is a healthcare REIT focused on Senior Housing, Outpatient Medical & Research, and Net Lease properties, primarily in the United States. The REIT has outperformed the Vanguard Real Estate Index Fund ETF in 2024 with a 22% total return. While Q2 2024 results were excellent and the company increased its guidance, I think the normalized FFO multiple and market-implied cap rate are quite elevated.
Ventas (VTR) Stock Rises 34.1% in Six Months: Here's How
Ventas (VTR) is poised to gain from a favorable demand in senior housing, backed by an expected rise in senior citizens' population despite the high interest rates environment.
Ventas (VTR) Q2 FFO Beats Estimates on Higher Same-Store NOI
Ventas' (VTR) Q2 results reflect occupancy and revenue growth in its same-store senior housing operating portfolio.
Compared to Estimates, Ventas (VTR) Q2 Earnings: A Look at Key Metrics
The headline numbers for Ventas (VTR) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Healthcare REIT Ventas raises full-year FFO per share forecast
Ventas raised the lower end of its forecast for annual funds from operations on Thursday, banking on continued strength for its assisted living and senior housing properties to drive performance.
Ventas (VTR) Q2 FFO and Revenues Top Estimates
Ventas (VTR) came out with quarterly funds from operations (FFO) of $0.80 per share, beating the Zacks Consensus Estimate of $0.79 per share. This compares to FFO of $0.75 per share a year ago.
Ventas (VTR) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Ventas (VTR), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2024.
What's in the Offing for Ventas (VTR) This Earnings Season?
Ventas' (VTR) Q2 earnings are likely to have benefitted from favorable SHOP operating trends, healthy demand for life-science real estate assets and accretive investments.
Here's Why You Should Retain Ventas (VTR) in Your Portfolio
Ventas (VTR) is poised to benefit by leveraging the rise in the aging population, growing outpatient visit trends and a healthy balance sheet. However, higher competition and interest rates are headwinds.
Ventas (VTR) Hits 52-Week High: Will the Stock Trend Higher?
Ventas (VTR) is expected to continue to benefiting from a favorable senior housing operating portfolio and outpatient visit trends.
Ventas: 4 Reasons To Be Cautious As Bulls Try And Sell Demographic Boom 2.0
"Silver Tsunami" refers to the aging baby boomer generation. Ventas, Inc. has been benefitting from this in the last 12 months and expects to benefit over the next 5 as well. We give you our Debbie Downer take with 4 reasons to be cautious.
